DRKS00023108
Completed
Not Applicable
on-invasive micro-RNA-based breast cancer diagnostics (Mammacheck) - Mammacheck
Prof. Dr. Thalia ErbesUniversitätsklinikum FreiburgKlinik für Frauenheilkunde0 sites2,004 target enrollmentDecember 8, 2020
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- healthy subjects
- Sponsor
- Prof. Dr. Thalia ErbesUniversitätsklinikum FreiburgKlinik für Frauenheilkunde
- Enrollment
- 2004
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Confirmed diagnosis of a primary, non pretreated breast cancer
- •\- female sex
- •\- signed declaration of consent
- •\- \>18 years old
- •Comparison test subjects:
- •\- \>18 years old
- •\- female sex
- •\- signed declaration of consent
Exclusion Criteria
- •Age: \<18 years
- •\- Condition after breast cancer disease
- •\- Pregnancy
- •\- Acute infections
- •Participation in a drug study within the last 3 months (exclusion by corresponding passage in the declaration of consent)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
An In-situ Detection for MicroRNABreast CancerNCT06529614Tongji Hospital100
Completed
Not Applicable
earch for developing the breast cancer diagnostic method using photoacoustic mammographyBreast cancerJPRN-UMIN000003406Graduate School of Medicine Kyoto University40
Active, not recruiting
Not Applicable
Breast cancer biomarkers and treatment targetsBreast cancerCancerMalignant neoplasm of breastISRCTN40576403niversity Hospital Southampton (UK)500
Completed
Not Applicable
on-invasive nodal staging in breast cancer with MRI Lymphography using gadofosveset; a pilot- study.Breast cancerLymph node metastases10006291NL-OMON36702Medisch Universitair Ziekenhuis Maastricht10
Completed
Not Applicable
on-invasive monitoring of breast cancer therapy using circulating tumor DNA from peripheral bloodNL-OMON43952Erasmus MC, Universitair Medisch Centrum Rotterdam90